Evidence map›Paper›PMID 37808681›Full record

ArticlebioRxiv : the preprint server for biology2023

Activin E is a TGFβ ligand that signals specifically through activin receptor-like kinase 7.

Kylie A Vestal, Chandramohan Kattamuri, Muhasin Koyiloth, Luisina Ongaro, James A Howard, Aimee Deaton, Simina Ticau, Aditi Dubey, Daniel J Bernard, Thomas B Thompson

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Kylie A VestalDepartment of Molecular and Cellular Biosciences, University of Cincinnati, Cincinnati, OH 45267, USA.
Chandramohan KattamuriDepartment of Molecular and Cellular Biosciences, University of Cincinnati, Cincinnati, OH 45267, USA.
Muhasin KoyilothDepartment of Molecular and Cellular Biosciences, University of Cincinnati, Cincinnati, OH 45267, USA.
Luisina OngaroDepartment of Pharmacology and Therapeutics, Centre for Research in Reproduction and Development, McGill University, Montreal, Quebec, Canada.
James A HowardDepartment of Pharmacology and Systems Physiology, University of Cincinnati, Cincinnati, OH 45267, USA.
Aimee DeatonAlnylam Pharmaceuticals, Cambridge, MA, USA.
Simina TicauAlnylam Pharmaceuticals, Cambridge, MA, USA.
Aditi DubeyAlnylam Pharmaceuticals, Cambridge, MA, USA.
Daniel J BernardDepartment of Pharmacology and Therapeutics, Centre for Research in Reproduction and Development, McGill University, Montreal, Quebec, Canada.
Thomas B ThompsonDepartment of Molecular and Cellular Biosciences, University of Cincinnati, Cincinnati, OH 45267, USA.
University of Cincinnati · USAlnylam Pharmaceuticals (United States) · USMcGill University · CA

Funding

Structural/functional characterization of TGFβ superfamily signaling and regulationR35GM134923 · NIGMS · UNIVERSITY OF CINCINNATI · PI THOMPSON, THOMAS B · 2020 to 2024
$2.6M
NIGMS NIH HHS R35 GM134923
6 · The paper itself

Abstract

Activins are one of the three distinct subclasses within the greater Transforming Growth Factor β (TGFβ) superfamily. First discovered for their critical roles in reproductive biology, activins have since been shown to alter cellular differentiation and proliferation. At present, members of the activin subclass include activin A (ActA), ActB, ActC, ActE, and the more distant members myostatin and GDF11. While the biological roles and signaling mechanisms of most activins class members have been well-studied, the signaling potential of ActE has remained largely unknown. Here, we characterized the signaling capacity of homodimeric ActE. Molecular modeling of the ligand:receptor complexes showed that ActC and ActE shared high similarity in both the type I and type II receptor binding epitopes. ActE signaled specifically through ALK7, utilized the canonical activin type II receptors, ActRIIA and ActRIIB, and was resistant to the extracellular antagonists follistatin and WFIKKN. In mature murine adipocytes, ActE invoked a SMAD2/3 response via ALK7, similar to ActC. Collectively, our results establish ActE as an ALK7 ligand, thereby providing a link between genetic and

Identifiers

PMID37808681
PMCPMC10557571
OpenAlexW4387012337

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.